These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11014991)

  • 1. Evidence for accumulation of advanced glycation end products in acute renal failure.
    Sebeková K; Heidland A; Waidheim A; Schinzel R
    Nephron; 2000 Oct; 86(2):186-7. PubMed ID: 11014991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increased levels of circulating advanced glycation end products in a model of acute renal insufficiency in rats].
    Boor P; Bozek P; Blazícek P; Syrová D; Schinzel R; Heidland A; Pecovová A; Sebeková K
    Cas Lek Cesk; 2001 Jun; 140(12):375-80. PubMed ID: 11503187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure.
    Sebeková K; Blazícek P; Syrová D; Krivosíková Z; Spustová V; Heidland A; Schinzel R
    Kidney Int Suppl; 2001 Feb; 78():S58-62. PubMed ID: 11168984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we reconsider the advanced glycation end product issue in hemodialysis patients?
    Schwedler SB; Wanner C
    Am J Kidney Dis; 2006 May; 47(5):923; author reply 923-4. PubMed ID: 16632035
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels of advanced glycation end products in children with renal disease.
    Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
    Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats.
    de Assis AM; Rech A; Longoni A; da Silva Morrone M; de Bittencourt Pasquali MA; Perry ML; Souza DO; Moreira JC
    Nutr Res; 2015 Jun; 35(6):512-22. PubMed ID: 25963123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
    van Deutekom AW; Niessen HW; Schalkwijk CG; Heine RJ; Simsek S
    Eur J Endocrinol; 2008 May; 158(5):655-60. PubMed ID: 18426823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a diet rich in advanced glycation end products in the rat remnant kidney model.
    Sebeková K; Faist V; Hofmann T; Schinzel R; Heidland A
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S48-51. PubMed ID: 12612952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosidine and its deposition in renal tissue in renal transplantation.
    Yoshida K; Yoneda T; Fujimoto K; Hirao Y; Konishi N
    Transplant Proc; 2005 Dec; 37(10):4266-72. PubMed ID: 16387094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
    Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
    Noori N; Tabibi H; Hosseinpanah F; Hedayati M; Nafar M
    Int J Vitam Nutr Res; 2013; 83(2):77-85. PubMed ID: 24491880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
    Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
    Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products and nutrition.
    Krajcovicová-Kudlácková M; Sebeková K; Schinzel R; Klvanová J
    Physiol Res; 2002; 51(3):313-6. PubMed ID: 12234125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis.
    Fujii EY; Nakayama M; Nakagawa A
    Reprod Sci; 2008 Dec; 15(10):1066-74. PubMed ID: 19088375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased binding of drugs and dyes to plasma proteins from rats with acute renal failure: effects of ureter ligation and intramuscular injection of glycerol.
    Bowmer CJ; Lindup WE
    Br J Pharmacol; 1979 Jun; 66(2):275-81. PubMed ID: 465881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.